How do I read and understand my Lung Cancer pathology report

Understanding Your Lung Cancer Pathology Report

A pathology report is one of the most important documents you'll receive after a biopsy or surgery. It tells you what type of lung cancer you have and provides critical information your doctors use to plan your treatment. Let me walk you through what to expect and what the key sections mean.

What Is a Pathology Report?

According to the NCCN Guidelines for Non-Small Cell Lung Cancer, a pathologist (a doctor who specializes in examining tissue under a microscope) examines your lung tissue sample and creates a detailed report. This report serves several purposes:

• Confirms the diagnosis - Is it actually cancer, and what type?
• Classifies the cancer subtype - Which specific type of lung cancer do you have?
• Determines how invasive it is - How deeply has the cancer grown?
• Identifies biomarkers - Are there specific mutations or markers that affect treatment options?
• Assesses surgical margins (if surgery was done) - Did the surgeon remove all the cancer?

---

Main Sections of Your Pathology Report

1. SPECIMEN INFORMATION

This section describes what tissue was removed and how it was obtained.

What to look for:

• Type of sample: biopsy, brushing, or surgical specimen
• Location in the lung
• How much tissue was collected

Why it matters: The amount and type of tissue affects what testing can be done. According to NCCN Guidelines, tissue must be preserved carefully for molecular testing (genetic testing), which is critical for treatment planning.

---

2. CLINICAL DIAGNOSIS / INDICATION

This is what your doctor suspected before the biopsy.

Example: "Suspected lung mass, rule out malignancy"

Why it matters: It shows what your doctor was investigating.

---

3. GROSS DESCRIPTION

This describes what the pathologist saw with the naked eye before looking under the microscope.

What you might see:

• Size of the tissue sample
• Color and texture
• Whether it looks abnormal

Plain language example: "A tan-white tissue fragment measuring 1.2 cm"

---

4. MICROSCOPIC FINDINGS / DIAGNOSIS ⭐ (Most Important)

This is the core of your report. It tells you what type of lung cancer you have.

Histologic Type (Cell Type)

According to the NCCN Guidelines, the main types of non-small cell lung cancer (NSCLC) include:

Adenocarcinoma

• Most common type of lung cancer
• Often found in the outer edges of the lungs
• Can occur in people who've never smoked
• Generally has better prognosis than some other types

Squamous Cell Carcinoma

• Usually found in the central airways
• More common in smokers
• Arises from flat cells lining the airways

Large Cell Carcinoma

• Less common
• Grows and spreads quickly

Mixed Types

• Contains more than one type of cancer cell

What to look for on your report: ✓ A clear statement like: "Adenocarcinoma" or "Squamous cell carcinoma"

Red flag: If your report says "NSCC-NOS" (non-small cell carcinoma, not otherwise specified), this means the pathologist couldn't determine the exact subtype. According to NCCN Guidelines, this should be used rarely. Ask your doctor if additional testing can be done to clarify the type.

---

5. GRADE / DIFFERENTIATION

This describes how abnormal the cancer cells look compared to normal lung cells.

Three levels:

• Well-differentiated - Cancer cells look fairly normal; generally slower growing
• Moderately differentiated - Cancer cells look somewhat abnormal
• Poorly differentiated - Cancer cells look very abnormal; generally faster growing

Why it matters: Grade helps predict how aggressively the cancer may behave.

---

6. INVASION & EXTENT

This describes how deeply the cancer has invaded into surrounding tissue.

What you might see:

• "Invasion into visceral pleura" (the lining around the lung)
• "Invasion into lymph nodes"
• "Invasion into blood vessels"

Why it matters: Deeper invasion generally means more advanced disease and affects staging and treatment options.

---

7. SURGICAL MARGINS (If Surgery Was Done)

This tells you whether cancer cells were found at the edges of the tissue removed.

What you want to see:

• ✓ "Negative margins" or "Clear margins" = Good news. All visible cancer was removed.

What concerns doctors:

• ✗ "Positive margins" or "Involved margins" = Cancer cells were found at the edge, meaning some cancer may have been left behind.

---

8. LYMPH NODE INVOLVEMENT

If lymph nodes were examined, the report describes whether cancer was found in them.

What you might see:

• "0 of 12 lymph nodes involved" = No cancer in lymph nodes (good sign)
• "2 of 15 lymph nodes involved" = Cancer found in some lymph nodes

Why it matters: Lymph node involvement is critical for staging and treatment planning.

---

9. BIOMARKER / MOLECULAR TESTING ⭐ (Very Important)

This is where genetic testing results appear. According to NCCN Guidelines, biomarker testing is essential because targeted therapies (drugs designed for specific mutations) can be very effective.

Common biomarkers tested:

EGFR Mutation

• If positive: You may be a candidate for EGFR-targeted therapy (like osimertinib)
• About 10-15% of lung cancers have this mutation
• More common in adenocarcinomas and non-smokers

ALK Rearrangement

• If positive: You may be a candidate for ALK-targeted therapy
• Found in about 3-5% of lung cancers
• More common in younger patients and adenocarcinomas

ROS1 Rearrangement

• If positive: You may be a candidate for ROS1-targeted therapy
• Found in about 1-2% of lung cancers

BRAF Mutation

• If positive: You may be a candidate for BRAF-targeted therapy
• Found in about 1-3% of lung cancers

PD-L1 Expression

• This is an immune marker, not a mutation
• Measured as a percentage (e.g., "PD-L1: 50%")
• Helps determine if immunotherapy (checkpoint inhibitors) might be effective
• According to NCCN Guidelines, PD-L1 levels help guide treatment decisions

What to look for:

• ✓ "Mutation detected" or "Positive" = Actionable finding; discuss targeted therapy options with your doctor
• ✓ "No mutation detected" or "Negative" = This particular mutation wasn't found (but doesn't mean no treatment options exist)
• ✓ "Insufficient material" = Not enough tissue to test; may need repeat biopsy

---

Questions to Ask Your Doctor About Your Pathology Report

1. "What type of lung cancer do I have, and what does that mean for my treatment?"

2. "Were all the biomarkers I need tested actually tested? If not, why not?"

   • According to NCCN Guidelines, tissue should be preserved for molecular testing, especially for advanced disease

3. "Do I have any actionable mutations that would make me a candidate for targeted therapy?"

4. "What do my PD-L1 results mean for immunotherapy options?"

5. "If my margins were positive, what does that mean for my treatment plan?"

6. "Are there any other tests or molecular studies you recommend based on my pathology results?"

7. "Can I get a copy of my full pathology report to keep for my records?"

---

Key Takeaway

Your pathology report is a roadmap for your treatment. The histologic type (adenocarcinoma, squamous cell, etc.) and biomarker results (EGFR, ALK, PD-L1, etc.) are the most critical sections because they directly determine which treatments your doctors will recommend.

Don't hesitate to ask your oncologist to explain any terms or results you don't understand. According to NCCN Guidelines, pathologic evaluation is done to determine